Coexistence of angiotensin II type-1 receptor A1166C and angiotensin-converting enzyme D/D polymorphism suggests susceptibility for small-vessel-associated ischemic stroke

NeuroMolecular Medicine

Volumn 8, Issue 3, 2006, Pages 353-360

  Szolnoki, Zoltán ^a   Maasz, Anita ^b   Magyari, Lili ^b   Horvatovich, Katalin ^b   Farago, Bernadett ^b   Somogyvari, Ferenc ^a,c   Kondacs, Andras ^a   Szabo, Mihaly ^a   Fodor, Lajos ^a   Bodor, Anita ^d   Hadarits, Ferenc ^e   Melegh, Bela ^b,f  

^a Pandy Kalman County Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Rethy Pal Hospital   (Hungary)

^e Markusovszky Teaching Hospital   (Hungary)

^f UNIVERSITY OF PÉCS   (Hungary)

Author keywords

ACE I D; Angiotensin; AT1R A1166C polymorphism; Network; Receptor; Stroke

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE;

ADULT; AGED; BLOOD VESSELS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 33745257595     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:8:3:353     Document Type: Article

References (26)

1. Agachan B., Isbir T., Yilmaz H., and Akoglu E. (2003) Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp. Mol. Med. 35, 545-549.
2. Brenner D., Labreuche J., Poirier O., et al. (2005) Renin-angiotensin- aldosterone system in brain infarction and vascular death. Ann. Neurol. 58, 131-138.
3. De Ciuceis C., Amiri F., Brassard P., et al. (2005) Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler. Thromb. Vasc. Biol. 25, 2106-2113.
4. De Gennaro Colonna V., Rigamonti A., Fioretti S., et al. (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur. J. Pharmacol. 516, 253-259.
5. Fukazawa R., Sonobe T., Hamamoto K., et al. (2004) Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr. Res. 56, 597-601.
6. Henderson S. O., Haiman C. A., and Mack W. (2004) Multiple polymorphisms in the renin-angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am. J. Med. Sci. 328, 266-273.
7. Higashi Y., Chayama K., and Yoshizumi M. (2005) Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress. Curr. Med. Chem. Cardiovasc. Hematol. Agents 3, 133-148.
8. Imai Y., Kuba K., Rao S., et al. (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112-116.
9. Jones A., Dhamrait S. S., Payne J. R., et al. (2003) Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 42, 500-506.
10. Kuba K., Imai Y., Rao S., et al. (2005) A crucial role of angiotensin converting enzyme 2 ( ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875-879.
11. Larose E. and Ganz P. (2004) Statins and endothelial dysfunction. Semin. Vasc. Med. 4, 333-346.
12. Malik F. S., Lavie C. J., Mehra M. R., et al. (1997) Renin-angiotensin system: genes to bedside. Am. Heart J. 134, 514-526.
13. Miller J. A. and Scholey J. W. (2004) The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr. Opin. Nephrol. Hypertens. 13, 101-106.
14. Miller S. A., Dykes D. D., and Polesky H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
15. Nicholls J. and Peiris M. (2005) Good ACE, bad ACE do battle in lung injury, SARS. Nat. Med. 11, 821, 822.
16. Rubattu S., DiAngelantonio E., Stanzione R., et al. (2004) Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J. Hypertens. 22, 2129-2134.
17. Saavedra J. M. (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol. Neurobiol. 25, 485-512.
18. Schmieder R. E. (2005) Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am. J. Hypertens. 18, 720-730.
19. Somogyvári F., Szolnoki Z., Márki-Zay J., et al. (2001) Real-time PCR assay with fluorescent hybridization probes for exact and rapid genotyping of the angiotensin-converting enzyme gene insertion/deletion polymorphism. Clin. Chem. 47, 1728, 1729.
20. Szolnoki Z., Somogyvari F., Kondacs A., et al. (2002) Evaluation of the interactions of common genetic mutations in stroke subtypes. J. Neurol. 249, 1391-1397.
21. Szolnoki Z., Somogyvari F., Kondacs A., et al. (2003) Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischemic stroke. J. Neurol. Neurosurg. Psychiatry 74, 1615-1620.
22. Szolnoki Z., Somogyvari F., Kondacs A., et al. (2004) Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurol. Scand. 109, 222-227.
23. Van Geel P. P., Pinto Y. M., Voors A. A., et al. (2000) Angiotenin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35, 717-721.
24. Watanabe S., Tagawa T., Yamakawa K., et al. (2005) Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler. Thromb. Vasc. Biol. 25, 2376-2380.
25. World Health Organization (1985) Report on diabetes mellitus. WHO Tech. Rep. Ser. 727.
26. Zhou J., Ando H., Macova M., et al. (2005) Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J. Cereb. Blood Flow Metab. 25, 878-886.